CanLiv Leadership
Board of Directors:
Melanie B. Thomas, MD 
President, CanLiv
Associate Director of Clinical Investigations,
Hollings Cancer Center
Grace E. DeWolff Chair of Medical Oncology
Associate Professor, Hollings Cancer Center, Medical University of South Carolina
Charleston, SC
Medical oncologist who specializes in treatment of and clinical research for patients with cancers of the bile ducts, gallbladder and liver.
Melvyn H. Blum
Treasurer, CanLiv
New York City, NY
Family member of individual affected by hepatobiliary cancer
Matthew V. Byrne III, Esq
Secretary, CanLiv
Byrne, Costello, and Pickard, P.C.
Syracuse, NY
Attorney with extensive expertise in establishing philanthropic organizations
Peter Shamamian, MD
Board Member, CanLiv
Chief of Surgery, Department of Veteran Affairs
Professor, Department of Surgery, Medical University of South Carolina
Charleston, SC
Surgical oncologist who specializes in treatment of and research for patients with cancers of the bile ducts, liver and pancreas.
Andrew X. Zhu, MD, PhD
Vice President, CanLiv
Director, Liver Cancer Research
Massachusettes General Hospital Cancer Center
Boston, MA
Medical oncologist who specializes in treatment of and clinical research for patients with cancers of the bile ducts, gallbladder and liver.
Tim Pawlick, MD, MPH
Board Member
John Hopkins
Baltimore, MD
Associate Professor of Surgery and Oncology, Hepatobiliary Surgery Program Director
Lewis Roberts, MD, Ch.B, PhD .aspx?width=30&height=30)
Board Member
Mayo Clinic
Rochester, MN
Liver specialist and scientist
Anthony El-Khoueiry, MD
Board Member
University of Southern California
Los Angeles, CA
Medical oncologist and internal medicine
Dale Whetstone
Board Member
Charlotte, NC
Family member/advocate
Last Updated on 4/18/2012 4:50:49 PM